Work

Esorubicin (deoxydoxorubicin) has low grade activity in malignant melanoma

Year: 1990

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/bf00171849

Authors: Howard Hochster, Myla Hunt, Michael Green, David Parkinson, Thomas Smith

Institutions: New York University, Harvard University, Dana-Farber Cancer Institute, NYU Langone Health

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: EASTERN COOPERATIVE ONCOLOGY GROUP, G5953508653, G644339941, Eastern Cooperative Oncology Group Operations Office, Cancer Center Support Grant, G964706321

OpenAlex ID: W2849254249

FWCI:

Cites: 12

Cited by: 1

Related to: 10